Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Apr 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5034699011 | Mitoxantrone only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5034700012 | Product containing only mitoxantrone in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mitoxantrone only product in parenteral dose form | Is a | Product containing mitoxantrone in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Mitoxantrone only product in parenteral dose form | Is a | Mitoxantrone only product | true | Inferred relationship | Some | ||
| Mitoxantrone only product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Mitoxantrone only product in parenteral dose form | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Some | ||
| Mitoxantrone only product in parenteral dose form | Has active ingredient | Mitoxantrone (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely mitoxantrone (as mitoxantrone hydrochloride) 2 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Is a | True | Mitoxantrone only product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR